(Q38393066)

2 September 2017

title

The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study (English)

1 reference

2 September 2017

1 reference

1

Josh D Woolley

1 reference

2 September 2017

7

Sophia Vinogradov

1 reference

2 September 2017

Peter A Arcuni

2

1 reference

2 September 2017

Christopher S Stauffer

3

1 reference

2 September 2017

Daniel Fulford

4

1 reference

2 September 2017

Dean S Carson

5

1 reference

2 September 2017

Steve Batki

6

1 reference

2 September 2017

publication date

3 May 2016

1 reference

2 September 2017

1 reference

2 September 2017

volume

233

1 reference

2 September 2017

issue

13

1 reference

2 September 2017

page(s)

2571-2580

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-016-4308-8

2 September 2017

exact match

0 references

cites work

Behavioral and social effects of heroin self-administration and withdrawal

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

The "Reading the Mind in the Eyes" Test Revised Version: A Study with Normal Adults, and Adults with Asperger Syndrome or High-functioning Autism

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

21 January 2018

12 December 2020

Social effects of oxytocin in humans: context and person matter

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Neural systems and cue-induced cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Theory of mind impairment: a distinct trait-marker for schizophrenia spectrum disorders and bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

A brief history of oxytocin and its role in modulating psychostimulant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Oxytocin improves "mind-reading" in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Oxytocin and social motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Understanding and using the Implicit Association Test: III. Meta-analysis of predictive validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Oxytocin increases retention of social cognition in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Impaired emotional facial expression recognition in alcoholics, opiate dependence subjects, methadone maintained subjects and mixed alcohol-opiate antecedents subjects compared with normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Acute morphine treatment and morphine tolerance/dependence alter immunoreactive oxytocin levels in the mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Oxytocin and addiction: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Complexity of oxytocin׳s effects in a chronic cocaine dependent population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Implicit and explicit drug-related cognitions during detoxification treatment are associated with drug relapse: an ecological momentary assessment study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Gender differences in interpersonal problems of alcohol-dependent patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Selective influences of oxytocin on the evaluative processing of social stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Intranasal oxytocin blocks alcohol withdrawal in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Does oxytocin affect mind-reading? A replication study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Opioid dependence treatment, including buprenorphine/naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Incentive-sensitization and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Role of oxytocin in the neuroadaptation to drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Oxytocin in learning and addiction: From early discoveries to the present.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Conditioning and opiate withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Comprehension of insincere communication in neurodegenerative disease: lies, sarcasm, and theory of mind

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Effects of buprenorphine/naloxone in opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Oxytocin administration enhances controlled social cognition in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4308-8

Influences of family and friends on client progress during drug abuse treatment

21 January 2018

1 reference

12 December 2020

Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats

1 reference

12 December 2020

Disposition of methadone in man after a single oral dose

1 reference

12 December 2020

Opioids: from physical pain to the pain of social isolation

1 reference

12 December 2020

Alternate cardiovascular baseline assessment techniques: vanilla or resting baseline

1 reference

12 December 2020

Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study

1 reference

12 December 2020

The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties

1 reference

12 December 2020

Reactivity of alcoholics and nonalcoholics to drinking cues.

1 reference

12 December 2020

Oxytocin blocks the development of heroin-enkephalin cross-tolerance in mice

1 reference

12 December 2020

Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates.

1 reference

12 December 2020

Neural systems underlying opiate addiction.

1 reference

12 December 2020

Self-control and implicit drinking identity as predictors of alcohol consumption, problems, and cravings

1 reference

12 December 2020

Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice

1 reference

12 December 2020

10.1007/S00213-016-4308-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1013658158

0 references

1 reference